Clinical trial
Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder
NCT00383786 · Baylor College of Medicine, Other · Completed
Key facts
| NCT number | NCT00383786 |
|---|---|
| Title | Substance P Antagonist in the Treatment of Posttraumatic Stress Disorder |
| Official title | Evaluation of the Efficacy of the NK1 Antagonist GR205171 in Posttraumatic Stress Disorder |
| Lead sponsor | Baylor College of Medicine, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | PTSD |
| Intervention type | Drug, Procedure |
| Interventions | NK1 Antagoist (GR205171), Psychophysiology (Trauma Script), Psychophysiology (Verbal Threat), Psychophysiology (Fear Conditioning), Psychophysiology (Affective Modulation), Psychophysiology (Heart rate variability), Lumbar Puncture, 24-hour plasma sampling, MRI |
| Enrollment | 47 |
| Start date | Sep 1, 2006 |
| Primary completion | Jun 1, 2009 |
| Completion | Jun 1, 2009 |
| First posted | Oct 4, 2006 |
| Last update posted | Jul 31, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: